143 related articles for article (PubMed ID: 9870472)
1. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.
Holdaas H; Hartmann A; Berg KJ; Lund K; Fauchald P
Nephrol Dial Transplant; 1998 Dec; 13(12):3096-102. PubMed ID: 9870472
[TBL] [Abstract][Full Text] [Related]
2. Effects of losartan and amlodipine on urinary albumin excretion and ambulatory blood pressure in hypertensive type 2 diabetic patients with overt nephropathy.
Yasuda G; Ando D; Hirawa N; Umemura S; Tochikubo O
Diabetes Care; 2005 Aug; 28(8):1862-8. PubMed ID: 16043724
[TBL] [Abstract][Full Text] [Related]
3. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
Praga M; Andrade CF; Luño J; Arias M; Poveda R; Mora J; Prat MV; Rivera F; Galceran JM; Ara JM; Aguirre R; Bernis C; Marín R; Campistol JM
Nephrol Dial Transplant; 2003 Sep; 18(9):1806-13. PubMed ID: 12937228
[TBL] [Abstract][Full Text] [Related]
4. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, controlled study of losartan in children with proteinuria.
Webb NJ; Lam C; Loeys T; Shahinfar S; Strehlau J; Wells TG; Santoro E; Manas D; Gleim GW
Clin J Am Soc Nephrol; 2010 Mar; 5(3):417-24. PubMed ID: 20089489
[TBL] [Abstract][Full Text] [Related]
6. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
Park HC; Xu ZG; Choi S; Goo YS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
[TBL] [Abstract][Full Text] [Related]
7. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ; Lewis JB
Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of losartan in children with Alport syndrome--results from a subgroup analysis of a prospective, randomized, placebo- or amlodipine-controlled trial.
Webb NJ; Lam C; Shahinfar S; Strehlau J; Wells TG; Gleim GW; Le Bailly De Tilleghem C
Nephrol Dial Transplant; 2011 Aug; 26(8):2521-6. PubMed ID: 21285125
[TBL] [Abstract][Full Text] [Related]
11. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Peng F; Lin J; Lin L; Tang H
Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of amlodipine and losartan on blood pressure and diurnal variation in hypertensive stroke patients: a prospective, randomized, double-blind, comparative parallel study.
Kwon HM; Shin JW; Lim JS; Hong YH; Lee YS; Nam H
Clin Ther; 2013 Dec; 35(12):1975-82. PubMed ID: 24296324
[TBL] [Abstract][Full Text] [Related]
13. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
Iñigo P; Campistol JM; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
J Am Soc Nephrol; 2001 Apr; 12(4):822-827. PubMed ID: 11274244
[TBL] [Abstract][Full Text] [Related]
14. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Donner K; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Kontula K; Hiltunen TP
J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
[TBL] [Abstract][Full Text] [Related]
15. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial.
Kloner RA; Neutel J; Roth EM; Weiss R; Weinberger MH; Thakker KM; Schwartz B; Shi H; Gregg AM;
Ann Pharmacother; 2008 Nov; 42(11):1552-62. PubMed ID: 18827176
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients.
el-Agroudy AE; Hassan NA; Foda MA; Ismail AM; el-Sawy EA; Mousa O; Ghoneim MA
Am J Nephrol; 2003; 23(5):300-6. PubMed ID: 12904684
[TBL] [Abstract][Full Text] [Related]
18. [Calcium channel blocking agents and albuminuria in diabetic and hypertensive patients. A pilot study].
Lamarre-Cliche M; Lambert R; Van Nguyen P; Cusson J; Wistaff R; Larochelle P
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):919-24. PubMed ID: 10989730
[TBL] [Abstract][Full Text] [Related]
19. Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial.
Fogari R; Mugellini A; Destro M; Corradi L; Lazzari P; Zoppi A; Preti P; Derosa G
Diabet Med; 2012 Jan; 29(1):24-31. PubMed ID: 21781149
[TBL] [Abstract][Full Text] [Related]
20. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Wu SC; Liu CP; Chiang HT; Lin SL
Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
